Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism : Risk factors and topographic distribution

Acta Neurologica Belgica

Volumn 99, Issue 3, 1999, Pages 176-181

  Akbostanci, M Cenk ^a   Atbasoglu E C ^b   Balaban, H ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b NONE

Author keywords

Drug induced dyskinesia; Drug induced parkinsonism; Risk factors; Tardive dyskinesia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; BELGIUM; BIPOLAR DISORDER; BODY POSTURE; CHEMICALLY INDUCED DISORDER; CROSS-SECTIONAL STUDY; DYSKINESIA; FEMALE; GAIT; HOSPITALIZATION; HUMAN; MALE; PARKINSON DISEASE; RISK FACTOR; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; BELGIUM; BIPOLAR DISORDER; CROSS-SECTIONAL STUDIES; DYSKINESIA, DRUG-INDUCED; FEMALE; GAIT; HUMANS; MALE; PARKINSON DISEASE, SECONDARY; POSTURE; RISK FACTORS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX;

EID: 0033192295     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Washington DC, American Psychiatric Association. 1994.
2. AYD F. J. A survey of drug-induced extrapyramidal reactions. J.A.M.A., 1961, 175 : 1054-1060.
3. BROWN K., WHITE T. The association among negative symptoms, movement disorders and frontal lobe psychological deficits in schizophrenic patients. Biol. Psychiatry, 1991, 30 : 1182-1190.
4. CALIGIURI M. P., LOHR J. B., BRACHA S., JESTE D. V. Clinical and instrumental assessment of neuroleptic-induced parkinsonism in patients with tardive dyskinesia. Biol. Psychiatry., 1991, 29 : 139-148.
5. CASEY D. E. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia. Psychiatric Clin. N. Am., 1993, 16 (3) : 589-610.
6. FAHN S., ELTON R. L., MEMBERS OF THE UPDRS DEVELOPMENT COMMITTEE. Unified Parkinson's Disease Rating Scale. In : Recent Developments in Parkinson's Disease. Vol. II". FAHN S., MARSDEN C. D., GOLDSTEIN M., CALNE D. B. (eds.). New York, Macmillan, 1987, 153-163.
7. GUNNE L. M., ANDREN P. E. An animal model for coexisting tardive dyskinesia and tardive parkinsonism : A glutamate hypothesis for tardive dyskinesia. Clin. Neuropharmacol., 1993, 16 : 90-95.
8. GUREJE O. The significance of subtyping tardive dyskinesia : a study of prevalence and associated factors. J. Neurol. Neurosurg. Psychiatry, 1989, 19 : 121-128.
9. GUY W. ECDEU Assessment Manual for Psychopharmacology, Revised. Washington DC, United States Department of Health, Education and Welfare, 1976.
10. HARDIE R. J., LEES A. J. Neuroleptic-induced Parkinson's syndrome : clinical features and results of treatment with levodopa. J. Neurol. Neurosurg. Psychiatry, 1988, 51 : 850-854.
11. HAUSNER R. S. Neuroleptic-induced parkinsonism and Parkinson's disease. J. Clin. Psychiatry, 1983, 44 : 13-16.
12. KIDGER T., BARNES T. R. E., TRAUER T., TAYLOR P. J. Subsyndromes of tardive dyskinesia. Psychol. Med., 1980, 10 : 513-520.
13. KLAWANS H. L., TANNER C. M., GOETZ C. G. Epidemiology and pathophysiology of tardive dyskinesias. In : "Advances In Neurology". JANKOVIC J., TOLOSA E. (eds.). New York, Raven Press, 1988, 185-197.
14. LANE R. D., GLAZER W. M., HANSEN T. E., , BERMAN W. H., KRAMER S. I. Assessment of tardive dyskinesia using the Abnormal Involuntary Movement Scale. J. Nerv. Ment. Dis., 1985, 173 : 353-357.
15. LIDDLE P. F., BARNES T. R. E., SPELLER J., KIBEL D. Negative symptoms as a risk factor for tardive dyskinesia in schizophrenia. Br. J. Psychiatry, 1993, 163 : 776-780.
16. LISHMAN W. A. Organic Psychiatry, Third Edition. Oxford, Blackwell, 1998, 639-646.
17. PAULSEN J. S., CALIGIURI M. P., PALMER B., MCADAMS L. A., JESTE D. V. Risk factors for orofacial and limbtruncal tardive dyskinesia in older patients : a prospective longitudinal study. Psychopharmacology, 1996, 123 : 307-14.
18. RAJPUT A. H., ROZDILSKY B., HORNYKIEWICZ O., SHANNAK K., LEE T., SEEMAN P. Reversible drug-induced parkinsonism. Arch. Neurol., 1982, 39 : 644-646.
19. RICHARDS M., MARDER K., COTE L., MAYEUX R. Interrater reliability of the Unified Parkinson's Disease Rating Scale Motor Examination. Mov. Disord., 1994, 9 : 89-91.
20. SANDYK R., KAY S. R. Risk factors for neuroleptic-induced movement disorders. Int J Neuroscience, 1991, 61 : 149-188.
21. SCHOOLER N. R., KANE J. M. Research diagnoses for tardive dyskinesia. Arch. Gen. Psychiatry, 1982, 39 : 486-487.
22. SHEPPARD C., MERLIS S. Drug-induced extrapyramidal symptoms : Their incidence and treatment. Am. J. Psychiatry, 1967, 123 : 886-889.
23. STEPHEN P. J., WILLIAMSON J. Drug-induced parkinsonism in the elderly. Lancet, 1984, ii : 1082-1083.
24. TARSY D., GRANACHER R., BRALOWER M. Tardive dyskinesia in young adults. Am. J. Psychiatry, 1977, 134 : 1032-1034.
25. VAN OS J., FAHY T., JONES P., HARVET I., TOONE B., MURRAY R. Tardive dyskinesia : who is at risk ? Acta Psychiatr. Scand., 1997, 96 : 206-216.
26. WADDINGTON J. L., YOUSSEF H. A., MOLLOY A. G., O'BOYLE K. M., PUGH M. T. Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia, clinical and animal studies. J. Clin. Psychiatry, 1985, 46 : 29-33.
27. WOLF M. E., CHEVESICH J., LEHRER E., MOSNAIM A. D. The clinical association of tardive dyskinesia and drug-induced parkinsonism. Biol. Psychiatry, 1983, 18 : 1181-1188.